Related references
Note: Only part of the references are listed.Lentivector Immunization Stimulates Potent CD8 T Cell Responses against Melanoma Self-Antigen Tyrosinase-Related Protein I and Generates Antitumor Immunity in Mice
Yanjun Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2009)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
DC activated via dectin-1 convert Treg into IL-17 producers
Fabiola Osorio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs
Xuexian O. Yang et al.
IMMUNITY (2008)
Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice
Nicolas Degauque et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Silvia Piconese et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis
Samantha L. Bailey-Bucktrout et al.
JOURNAL OF IMMUNOLOGY (2008)
T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase Cθ
Su-Yi Tseng et al.
JOURNAL OF IMMUNOLOGY (2008)
被撤回的出版物: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo (Retracted article. See vol. 184, pg. 6556, 2010)
Suresh Radhakrishnan et al.
JOURNAL OF IMMUNOLOGY (2008)
Murine cytomegalovirus induces a polyfunctional CD4 T cell response
Ramon Arens et al.
JOURNAL OF IMMUNOLOGY (2008)
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease
Luigina Romani et al.
NATURE (2008)
Induction and effector functions of TH17 cells
Estelle Bettelli et al.
NATURE (2008)
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Natural and TGF-β-induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
David A. Horwitz et al.
TRENDS IN IMMUNOLOGY (2008)
Creating immune privilege: active local suppression that benefits friends, but protects foes
Andrew L. Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3
Luke M. Williams et al.
NATURE IMMUNOLOGY (2007)
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19(+) dendritic cells
Anna K. Manlapat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Cutting edge: Regulatory T cells induce CD4(+)CD25(-)Foxp3(-) T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta
LiLi Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
The tumor-draining lymph node as an immune-privileged site
David H. Munn et al.
IMMUNOLOGICAL REVIEWS (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance
Michiko Shimoda et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
JA Guevara-Patiño et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Coping with stress: eIF2 kinases and translational control
RC Wek et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Toll-like receptor 2 controls expansion and function of regulatory T cells
RPM Sutmuller et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tumor-infiltrating dendritic cells are potent antigen-presenting cells able to activate T cells and mediate tumor rejection
O Preynat-Seauve et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge: Silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant
C Orabona et al.
JOURNAL OF IMMUNOLOGY (2005)
Activation requirements for the induction of CD4+CD25+ T cell suppressor function
AM Thornton et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells
Z Fehérvári et al.
INTERNATIONAL IMMUNOLOGY (2004)
An essential function for the nuclear receptor ROR gamma t in the generation of fetal lymphoid tissue inducer cells
G Eberl et al.
NATURE IMMUNOLOGY (2004)
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86
C Orabona et al.
NATURE IMMUNOLOGY (2004)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells
C Pasare et al.
SCIENCE (2003)
CpG are efficient Adjuvants for specific CTL induction against tumor antigen-derived peptide
I Miconnet et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
